North America, the epinephrine market, is anticipated to reach US$ 1,598.99 Mn in 2027 from US$ 841.86 Mn in 2019. The market is projected to grow with a CAGR of 8.5% from 2020-2027.
The epinephrine market is growing primarily due to the fast growth of auto-injector production in North America and the growing prevalence of anaphylaxis cases in the North American region that are boosting the market over the years. Restraining factors, such lack of availability of epinephrine drug, are likely to damage the growth of the market in the coming years. On the other hand, growing R&D expenditure for growing pipeline of epinephrine is expected to have a positive impact on the growth of the North American epinephrine market in the coming years.
Anaphylaxis is a severe, life?threatening allergic reaction characterized by symptoms such as skin redness and itching, swallowing and breathing difficulties, wheezing, rapid breathing rate (tachypnoea), accelerated heart rate (tachycardia), and falling blood pressure. It may involve multiple systems of human body. Anaphylaxis is caused by exposure to an allergen (foods, insect stings, or medicines) that is recognized as a non-self by a human body.
The incidence of anaphylaxis is increasing, as per Allergy Facts by the American College of Allergy, Asthma & Immunology, and more than 50 million Americans experience different types of allergies every year. Moreover, it also lists allergies as the sixth-leading cause of chronic illness in the US and the most common health issues in children. In 2015, 8.2% of adults and 8.4% of children were diagnosed with hay fever. According to the Asthma and Allergy Foundation of America, in the last few years, hospital visits have also increased due to food allergic reaction. According to Food Allergy Research & Education, ~32 million Americans are living with life-threatening food allergies, and there are 200,000 visits to the emergency room every year due to food allergies. Allergies put an economic burden on healthcare systems in many countries; for example, according to Allergy Facts, the annual cost of managing the cases of allergies is more than USD 18 billion in the US. Anaphylaxis requires immediate medical treatment, and it can turn lethal if not treated properly. ~90?100 Americans die every year due to anaphylaxis caused by insect stings. Therefore, the demand for epinephrine is expected to increase during the forecast period.
In 2019, the auto-injectors accounted for the largest market share in the North American epinephrine market. Epinephrine auto-injectors are measured dosages and are also used to treat life-threatening allergic reactions. The epinephrine auto-injectors can be self-administered. The auto-injectors segment is also estimated to mark the highest CAGR in the market during the forecast period, owing to the increasing technological development that is enabling the alternative treatment of anaphylaxis by the various generic drugs.
In 2019, the anaphylaxis segment, held the most significant market share of the epinephrine market by the application. This segment is also anticipated to hold a considerable portion of the market in 2027, owing to the need for treatment of anaphylaxis and other allergies for the people. The segment is also anticipated to witness growth at a significant rate during the forecast period.
Some of the significant primary and secondary sources for epinephrine included in the report are World Health Organization (WHO), Food and Drug Administration (FDA), Food Allergy Research & Education, Centers for Disease Control and Prevention (CDC), Asthma and Allergy Foundation of America.
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Epinephrine Market ? By Product Type
1.3.2 North America Epinephrine Market ? By Application
1.3.3 North America Epinephrine Market ? By Distribution Channel
1.3.4 North America Epinephrine Market ? By Country
2. North America Epinephrine Market ? Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Epinephrine Market ? Market Landscape
4.1 overview
4.2 PEST Analysis
4.2.1 Epinephrine Market - North America PEST Analysis
4.3 Expert Opinion
5. North America Epinephrine Market - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Fast growth of Auto-injector production
5.1.2 Increasing Prevalence Of Anaphylaxis Cases
5.2 Key Restraints
5.2.1 Lack of Availability of Epinephrine
5.3 Key Market Opportunities
5.3.1 Growing Pipeline of Epinephrine
5.4 Future Trend
5.4.1 Novel Drug Delivery Systems
5.5 Impact Analysis
6. Epinephrine Market ? North America Analysis
6.1 North America Epinephrine Market Revenue Forecasts and Analysis
6.2 Positioning Of Key Players
7. North America Epinephrine Market Analysis And Forecasts To 2027 ? Product Type
7.1 Overview
7.2 North America Epinephrine Market, By Product Type 2019 & 2027 (%)
7.2.1 North America Epinephrine Market Revenue and Forecasts to 2027, By Product Type (US$ Mn)
7.3 Auto-Injectors
7.3.1 Overview
7.3.2 North America Auto-Injectors Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Prefilled Syringes
7.4.1 Overview
7.4.2 North America Prefilled Syringes Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 Ampoules and Vials
7.5.1 Overview
7.5.2 North America Ampoules and Vials Market Revenue and Forecasts to 2027 (US$ Mn)
8. North America Epinephrine Market Analysis? By Application
8.1 Overview
8.2 North America Epinephrine Market, By Application 2019-2027 (%)
8.2.1 North America Epinephrine Market Revenue and Forecasts to 2027, By Application (US$ Mn)
8.3 Anaphylaxis
8.3.1 Overview
8.3.2 North America Anaphylaxis Market Revenue and Forecasts to 2027 (US$ Mn)
8.4 Cardiac Arrest
8.4.1 Overview
8.4.2 North America Cardiac Arrest Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 Respiratory Disorders
8.5.1 Overview
8.5.2 North America Respiratory Disorders Market Revenue and Forecasts to 2027 (US$ Mn)
8.6 Superficial Bleeding
8.6.1 Overview
8.6.2 North America Superficial Bleeding Market Revenue and Forecasts to 2027 (US$ Mn)
9. North America Epinephrine Market Analysis? By Distribution Channel
9.1 Overview
9.2 North America Epinephrine Market, By Distribution Channel 2019-2027 (%)
9.2.1 North America Epinephrine Market Revenue and Forecasts to 2027, By Distribution Channel Application (US$ Mn)
9.3 Retail Pharmacies
9.3.1 Overview
9.3.2 North America Retail Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
9.4 Hospital Pharmacies
9.4.1 Overview
9.4.2 North America Hospital Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
9.5 Online Pharmacies
9.5.1 Overview
9.5.2 North America Online Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)
10. Epinephrine Market Revenue And Forecasts To 2027 Geographical Analysis
10.1 North America Epinephrine Market Revenue and Forecasts To 2027
10.1.1 Overview
10.1.2 North America Epinephrine Market, Revenue and Forecast to 2027 (US$ Mn)
10.1.3 North America Epinephrine Market, Revenue and Forecast to 2027, by Product Type (US$ Mn)
10.1.4 North America Epinephrine Market, Revenue and Forecast to 2027, by Application (US$ Mn)
10.1.5 North America Epinephrine Market, Revenue and Forecast to 2027, by Distribution Channel (US$ Mn)
10.1.6 North America Epinephrine Market, Revenue and Forecast to 2027, by Country (%)
10.1.7 United States
10.1.7.1 US Epinephrine Market, Revenue and Forecast to 2027 (US$ Mn)
10.1.7.2 US Epinephrine Market, Revenue and Forecast to 2027, by Product Type (US$ Mn)
10.1.7.3 US Epinephrine Market, Revenue and Forecast to 2027, by Application (US$ Mn)
10.1.7.4 US Epinephrine Market, Revenue and Forecast to 2027, by Distribution Channel (US$ Mn)
10.1.8 Canada
10.1.8.1 Canada Epinephrine Market, Revenue and Forecast to 2027 (US$ Mn)
10.1.8.2 Canada Epinephrine Market, Revenue and Forecast to 2027, by Product Type(US$ Mn)
10.1.8.3 Canada Epinephrine Market, Revenue and Forecast to 2027, by Application(US$ Mn)
10.1.8.4 Canada Epinephrine Market, Revenue and Forecast to 2027, by Distribution Channel (US$ Mn)
10.1.9 Mexico
10.1.9.1 Mexico Epinephrine Market, Revenue and Forecast to 2027 (US$ Mn)
10.1.9.2 Mexico Epinephrine Market, Revenue and Forecast to 2027, by Product Type(US$ Mn)
10.1.9.3 Mexico Epinephrine Market, Revenue and Forecast to 2027, by Application(US$ Mn)
10.1.9.4 Mexico Epinephrine Market, Revenue and Forecast to 2027, by Distribution Channel (US$ Mn)
11. North America Epinephrine Market ?Industry Landscape
11.1 Overview
11.2 Growth Strategies In The Epinephrine Market, 2015-2019
11.3 Organic Growth Strategies
11.3.1 Overview
11.4 Inorganic Growth Strategies
11.4.1 Overview
11.5 Intranasal Epinephrine Spray?Clinical Trials
11.5.1 Overview
12. North America Epinephrine Market- Key Company Profiles
12.1 ALK-Abell? A/S
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Abbott
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Amneal Pharmaceuticals, Inc.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Kaleo, Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Teva Pharmaceutical Industries Ltd
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 BIOPROJET
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Medeca Pharma AB
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Novartis AG
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 MYLAN N.V.
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Erythpharm
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About
13.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Epinephrine Market Revenue and Forecasts To 2027, By Product Type (US$ Mn)
Table 2. North America Epinephrine Market Revenue and Forecasts To 2027, By Application (US$ Mn)
Table 3. North America Epinephrine Market Revenue and Forecasts To 2027, By Distribution Channel (US$ Mn)
Table 4. North America Epinephrine Market, Revenue and Forecast to 2027, by Product Type(US$ Mn)
Table 5. North America Epinephrine Market, Revenue and Forecast to 2027, by Application (US$ Mn)
Table 6. North America Epinephrine Market, Revenue and Forecast to 2027, by Distribution Channel (US$ Mn)
Table 7. US Epinephrine Market Revenue and Forecast To 2027, by Product Type(US$ Mn)
Table 8. US Epinephrine Market, Revenue and Forecast To 2027, by Application (US$ Mn)
Table 9. US Epinephrine Market, Revenue and Forecast To 2027, by Distribution Channel (US$ Mn)
Table 10. Canada Epinephrine Market Revenue and Forecast To 2027, by Product Type (US$ Mn)
Table 11. Canada Epinephrine Market Revenue and Forecast To 2027, by Application (US$ Mn)
Table 12. Canada Epinephrine Market, Revenue and Forecast To 2027, by Distribution Channel (US$ Mn)
Table 13. Mexico Epinephrine Market Revenue and Forecast To 2027, by Product Type (US$ Mn)
Table 14. Mexico Epinephrine Market Revenue and Forecast To 2027, by Application (US$ Mn)
Table 15. Mexico Epinephrine Market, Revenue and Forecast To 2027, by Distribution Channel (US$ Mn)
Table 16. Recent Organic Growth Strategies in the Epinephrine market
Table 17. Recent Inorganic Growth Strategies In The Epinephrine Market
Table 18. Developments For The Intranasal Epinephrine Spray, By Companies
Table 19. Glossary of Terms, Epinephrine Market
The List of Companies - North America Epinephrine Market
1. Mylan N.V.
2. Teva Pharmaceuticals Ltd.
3. Amneal Pharmaceuticals LLC
4. ALK-Abell? A/S
5. Abbott
6. Kaleo, Inc
7. BIOPROJET
8. Medeca Pharma AB
9. Novartis AG
10. Erythpharm